Revenue ($USD) : $1,707,905,626
Revenue (foreign currencies) : 18,119,000,000 SEK kr
R&D spend : $132,341,713
Employees : 4,641
Fiscal year end : 4/30/2024
CEO : Gustaf Salford

www.elekta.com

Elekta develops precision radiation therapy devices and oncology software. In 2024, the company purchased Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent portfolio and expanded its radiation oncology software partnership with GE HealthCare. –CN